-
Common origin and somatic mutation patterns of composite lymphomas and leukemias
Study
EGAS50000001017
-
Common origin and somatic mutation patterns of composite lymphomas and leukemias
Dataset
EGAD50000001486
-
DAC for lymphoma IFZ Essen
Dac
EGAC50000000521
-
Bulk RNA sequencing of 36 multi-region IPMN–PDAC tumours comprising 160 sequencing runs
Dataset
EGAD50000002215
-
Single cell RNA and ATAC sequencing data from GBM patients
Study
EGAS50000000547
-
Effects of GATA4-inhibiting compound 3i-2012 on HB-243 hepatoblastoma cells
Study
EGAS50000000999
-
Multiple Myeloma treated with BCL2 inhibitor based treatment
Study
EGAS50000001479
-
RNA sequencing of untreated head and neck cancer patient-derived xenografts (PDXs) and matched patient tumor tissue.
Study
EGAS50000001595
-
Whole Genome Sequencing from patients with multiple myeloma treated with BCL2 inhibitor based treatment
Dataset
EGAD50000002132
-
RNA sequencing of untreated head and neck cancer patient-derived xenografts (PDXs) and matched patient tumor tissue.
Dataset
EGAD50000002278
-
Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options; a feasibility study
Study
EGAS50000001583
-
Whole exome sequencing data of matched pairs of primary tumour and normal frozen tissue of seven osteosarcoma patients
Dataset
EGAD50000002264
-
WES
Dataset
EGAD50000000380
-
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis
Study
EGAS50000000825
-
Five Mantle Cell Lymphoma Patients Before and After Failure of Standard Chemotherapy
Dataset
EGAD50000001213
-
Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor
Study
EGAS50000000811
-
Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFkB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastoma
Study
EGAS50000001291
-
Whole-genome sequencing study of uveal melanoma
Study
EGAS50000001603
-
Rare Germline Variants in CDKN2A-Negative Children and Adolescents with Cutaneous Melanoma
Study
EGAS50000001311
-
Single-cell multi-omic profiling of glioblastoma-associated myeloid cells
Study
EGAS00001004871
-
Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche
Study
EGAS50000001581
-
Neuroblastoma_MP-PCR_MultiplexPCR_TargetedSequencing_BAMs
Dataset
EGAD50000002260
-
Transcriptomic profiling of myeloid cells from secondary lymphoid organs (lymph nodes and tonsils) from lymphoma patients and controls.
Study
EGAS50000001135
-
IDH1 Somatic Mutation Profile in Intrahepatic Cholangiocarcinoma
Study
EGAS50000001638
-
Targeted Next-Generation Sequencing Data of IDH1 Exon 4 in Intrahepatic Cholangiocarcinoma Samples
Dataset
EGAD50000002345
-
Ankara Bilkent City Hospital Clinical Research Ethics Committee
Dac
EGAC50000000940
-
Whole-exome sequencing (WES) analysis of untreated head and neck cancer patient-derived xenografts (PDXs) matched patient tumor tissue and normal mucosa tissue.
Study
EGAS50000001622
-
Whole-exome sequencing (WES) analysis of untreated head and neck cancer patient-derived xenografts (PDXs) matched patient tumor tissue and normal mucosa tissue.
Dataset
EGAD50000002325
-
Whole-genome sequencing of cell-free DNA from pancreatic and breast cancer cohorts for fragmentomic and tumor fraction analysis
Study
EGAS50000001620
-
Bleomycin Induced Pneumonitis cohort of the Exceptional Responders Program of the Garvan Institute of Medical Research
Study
EGAS50000001545
-
Bleomycin Induced Pneumonitis WGS dataset
Dataset
EGAD50000002221
-
WGS data from 20 cholangiocarcinoma cases
Dataset
EGAD50000002307
-
Optimized large-scale longitudinal biorepository of gastroesophageal adenocarcinoma patient-derived organoids
Study
EGAS50000001614
-
Optimized large-scale longitudinal biorepository of gastroesophageal adenocarcinoma patient-derived organoids: High-fidelity models for personalized treatment to overcome resistance
Dataset
EGAD50000002315
-
The DIRECT study: A roadmap for ctDNA-based risk prediction, molecular profiling and MRD detection in Diffuse Large B Cell Lymphoma
Study
EGAS50000000968
-
Sequencing data for Clinical Trial
Study
EGAS50000001144
-
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Study
EGAS00001007160
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing
Study
EGAS00001004760
-
ALK_inhibitors_in_the_context_of_ALK_dependent_cancer_cell_lines
Study
EGAS00001000082
-
Chordoma_Exome_Sequencing
Study
EGAS00001000188
-
The_genomic_architecture_of_mesothelioma_
Study
EGAS00001000353
-
Chordoma_Sequencing_Project_Whole_Genome
Study
EGAS00001000409
-
Whole genome bisulfite sequencing of hepatitis B virus-associated hepatocellular carcinoma tumor and non-cancerous samples
Study
EGAS00001002230
-
ICGC Oesophageal adenocarcinoma - pilot samples
Study
EGAS00001000559
-
Burden_of_Disease_in_Sarcoma
Study
EGAS00001000087
-
Mutational_Signatures_of_relapse_in_rectal_cancer_FFPE_samples_in_the_CR07_clinical_trial
Study
EGAS00001000651
-
Volasertib preclinical activity in high-risk hepatoblastoma
Study
EGAS00001004827
-
Genomic analysis of seminomas
Study
EGAS00001000943
-
Comprehensive miRNA Sequence Analysis Reveals Survival Differences in Diffuse Large B-cell Lymphoma Patients
Study
EGAS00001001025